Discover 1 curated intelligence briefings related to this specific topic.
The race to reverse aging has moved from the fringes of elite clinics to the consumer bloodstream. While the launch of mass-market biological age tests signals a new era of accessibility, a landmark Yale study warns that most current longevity interventions fail to actually shift the epigenetic clock.
